Samik Pharmaceutical Delays Incheon Plant Expansion Completion to February 2027

PUBT · 1d ago
Samik Pharmaceutical Delays Incheon Plant Expansion Completion to February 2027
  • Samik Pharmaceutical postpones completion of its Incheon plant annex to Feb. 28, 2027, from Oct. 31, 2026.
  • The corrected investment budget falls to KRW 7.09 billion from KRW 7.27 billion, representing 13.64% of equity.
  • The revisions reflect design changes, construction delays and adjustments for higher material costs.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Samik Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261030900736), on October 30, 2026, and is solely responsible for the information contained therein.